medigraphic.com
ISSN 0001-0944 (Impreso)
Órgano Oficial de la Asociación Dental Mexicana

2017, Número 6

<< Anterior Siguiente >>

Rev ADM 2017; 74 (6)


Herramientas invasivas y no invasivas para el diagnóstico de cáncer oral. Revisión de la literatura

Pérez BHJ

Idioma: Español
Referencias bibliográficas: 37
Paginas: 308-314
Archivo PDF: 197.33 Kb.


RESUMEN

El cáncer oral es una neoplasia frecuente a nivel mundial; su diagnóstico se realiza de forma tardía por lo menos en un 50-60% de los casos, lo que empeora el pronóstico de los pacientes, ya que a mayor estadio, mayor es la tasa de mortalidad. Por lo tanto, es fundamental contar con herramientas que permitan realizar un diagnóstico temprano y tratamiento oportuno, sobre todo cuando existen lesiones premalignas clínicamente identificables. En el presente estudio se revisan las herramientas invasivas y no invasivas (modernas y antiguas) que han demostrado utilidad para el diagnóstico de cáncer oral; se basan tanto en técnicas ampliamente disponibles en la práctica clínica como en otras aún no disponibles, pero que podrían implementarse con una apropiada coordinación entre el profesional dedicado a la clínica y los investigadores.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Bisen PS, Khan Z, Bundela S. Biology of oral cancer. Key apoptotic regulators. Boca Raton Florida, USA: CRC Press Taylor & Francis Group; 2014. p. 49.

  2. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010; 60 (5): 277-300.

  3. Radhika T, Jeddy N, Nithya S, Muthumeenakshi RM. Salivary biomarkers in oral squamous cell carcinoma —An insight. J Oral Biol Craniofac Res. 2016; 6 (Suppl 1): S51-S54.

  4. Baykul T, Yilmaz HH, Aydin U, Aydin MA, Aksoy M, Yildirim D. Early diagnosis of oral cancer. J Int Med Res. 2010; 38 (3): 737-749.

  5. Chen GS, Chen CH. A study on survival rates of oral squamous cell carcinoma. Kaohsiung J Med Sci. 1996; 12 (6): 317-325.

  6. Sciubba JJ. Oral cancer. The importance of early diagnosis and treatment. Am J Clin Dermatol. 2001; 2 (4): 239-251.

  7. Mishra A, Verma M. Cancer biomarkers: are we ready for the prime time? Cancers (Basel). 2010; 2 (1): 190-208.

  8. Habis AH, Vernon SD, Lee DR, Verma M, Unger ER. Molecular quality of exfoliated cervical cells: implications for molecular epidemiology and biomarker discovery. Cancer Epidemiol Biomarkers Prev. 2004; 13 (3): 492-496.

  9. Wilder-Smith P, Osann K, Hanna N, El Abbadi N, Brenner M, Messadi D et al. In vivo multiphoton fluorescence imaging: a novel approach to oral malignancy. Lasers Surg Med. 2004; 35 (2): 96-103.

  10. Oliveira AP, Bitar RA, Silveira L, Zângaro RA, Martin AA. Near-infrared Raman spectroscopy for oral carcinoma diagnosis. Photomed Laser Surg. 2006; 24 (3): 348-353.

  11. Harris AT, Lungari A, Needham CJ, Smith SL, Lones MA, Fisher SE et al. Potential for Raman spectroscopy to provide cancer screening using a peripheral blood sample. Head Neck Oncol. 2009; 1: 34.

  12. Adeyemi BF, Kolude B. Clinical presentation of oral squamous cell carcinoma. Niger Postgrad Med J. 2013; 20 (2): 108-110.

  13. Vorvick LJ. No invasivo. Enciclopedia médica de la Biblioteca Nacional de Medicina de Estados Unidos de Norteamérica. Tomado de: https://medlineplus.gov/spanish/ency/article/002269.htm

  14. Vokes EE, Weichselbaum RR, Lippman SM, Hong WK. Head and neck cancer. N Engl J Med. 1993; 328 (3): 184-194.

  15. Neville BW, Day TA. Oral cancer and precancerous lesions. CA Cancer J Clin. 2002; 52 (4): 195-215.

  16. Scully C, Bagan JV, Hopper C, Epstein JB. Oral cancer: current and future diagnostic techniques. Am J Dent. 2008; 21 (4): 199-209.

  17. Ghalwash DM, El Gaaly K, Zahran FM, Shaker O, El-Fol HA. The diagnostic and prognostic value of salivary sCD44 level determination in oral malignant and potentially premalignant lesions. Advances in Environmental Biology. 2012; 6 (1): 302-310.

  18. Nagler RM, Barak M, Peled M, Ben-Aryeh H, Filatov M, Laufer D. Early diagnosis and treatment monitoring roles of tumor markers Cyfra 21-1 and TPS in oral squamous cell carcinoma. Cancer. 1999; 85 (5): 1018-1025.

  19. Hu S, Arellano M, Boontheung P, Wang J, Zhou H, Jiang J et al. Salivary proteomics for oral cancer biomarker discovery. Clin Cancer Res. 2008; 14 (19): 6246-6252.

  20. Gleber-Netto FO, Yakob M, Li F, Feng Z, Dai J, Kao HK et al. Salivary biomarkers for detection of oral squamous cell carcinoma in a Taiwanese population. Clin Cancer Res. 2016; 22 (13): 3340-3347.

  21. Brinkmann O, Kastratovic DA, Dimitrijevic MV, Konstantinovic VS, Jelovac DB, Antic J et al. Oral squamous cell carcinoma detection by salivary biomarkers in a Serbian population. Oral Oncol. 2011; 47 (1): 51-55.

  22. Li Y, St John MA, Zhou X, Kim Y, Sinha U, Jordan RC et al. Salivary transcriptome diagnostics for oral cancer detection. Clin Cancer Res. 2004; 10 (24): 8442-8450.

  23. Mizukawa N, Sugiyama K, Fukunaga J, Ueno T, Mishima K, Takagi S et al. Defensin-1, a peptide detected in the saliva of oral squamous cell carcinoma patients. Anticancer Res. 1998; 18 (6B): 4645-4649.

  24. Arellano-Garcia ME, Hu S, Wang J, Henson B, Zhou H, Chia D et al. Multiplexed immunobead-based assay for detection of oral cancer protein biomarkers in saliva. Oral Dis. 2008; 14 (8): 705-712.

  25. Connolly JM, Davies K, Kazakeviciute A, Wheatley AM, Dockery P, Keogh I et al. Non-invasive and label-free detection of oral squamous cell carcinoma using saliva surface-enhanced Raman spectroscopy and multivariate analysis. Nanomedicine. 2016; 12 (6): 1593-1601.

  26. Kurokawa H, Tsuru S, Okada M, Nakamura T, Kajiyama M. Evaluation of tumor markers in patients with squamous cell carcinoma in the oral cavity. Int J Oral Maxillofac Surg. 1993; 22 (1): 35-38.

  27. Kurokawa H, Yamashita Y, Tokudome S, Kajiyama M. Combination assay for tumor markers in oral squamous cell carcinoma. J Oral Maxillofac Surg. 1997; 55 (9): 964-966.

  28. Krimmel M, Hoffmann J, Krimmel C, Cornelius CP, Schwenzer N. Relevance of SCC-Ag, CEA, CA 19.9 and CA 125 for diagnosis and follow-up in oral cancer. J Craniomaxillofac Surg. 1998; 26 (4): 243-248.

  29. Sakata J, Yoshida R, Matsuoka Y, Nagata M, Hirosue A, Kawahara K et al. Predictive value of the combination of SMAD4 expression and lymphocyte infiltration in malignant transformation of oral leukoplakia. Cancer Med. 2017; 6 (4): 730-738.

  30. Garnis C, Chari R, Buys TP, Zhang L, Ng RT, Rosin MP et al. Genomic imbalances in precancerous tissues signal oral cancer risk. Mol Cancer. 2009; 8: 50.

  31. Lajer CB, Nielsen FC, Friis-Hansen L, Norrild B, Borup R, Garnæs E et al. Different miRNA signatures of oral and pharyngeal squamous cell carcinomas: a prospective translational study. Br J Cancer. 2011; 104 (5): 830-840.

  32. Bhat S, Kabekkodu SP, Jayaprakash C, Radhakrishnan R, Ray S, Satyamoorthy K. Gene promoter-associated CpG island hypermethylation in squamous cell carcinoma of the tongue. Virchows Arch. 2017; 470 (4): 445-454.

  33. El-Naggar AK, Mao L, Staerkel G, Coombes MM, Tucker SL, Luna MA et al. Genetic heterogeneity in saliva from patients with oral squamous carcinomas: implications in molecular diagnosis and screening. J Mol Diagn. 2001; 3 (4): 164-170.

  34. Sahu AK, Dhoot S, Singh A, Sawant SS, Nandakumar N, Talathi-Desai S et al. Oral cancer screening: serum Raman spectroscopic approach. J Biomed Opt. 2015; 20 (11): 115006.

  35. Bailey AM, Mao Y, Zeng J, Holla V, Johnson A, Brusco L et al. Implementation of biomarker-driven cancer therapy: existing tools and remaining gaps. Discov Med. 2014; 17 (92): 101-114.

  36. Bigler LR, Streckfus CF, Dubinsky WP. Salivary biomarkers for the detection of malignant tumors that are remote from the oral cavity. Clin Lab Med. 2009; 29 (1): 71-85.

  37. Beckman RA, Chen C. Efficient, adaptive clinical validation of predictive biomarkers in cancer therapeutic development. Adv Exp Med Biol. 2015; 867: 81-90.




2020     |     www.medigraphic.com